
Lombard Medical Technologies (LMT) has a significant shareholding (balance sheet value of £3 million) in Vascular Concepts Holdings Ltd, a profitable cardiovascular company that develops and manufactures stent technology including new drug eluting devices. It has established a good position in Asian markets and is beginning to expand in Europe.

